HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monoamine oxidase a and catechol-o-methyltransferase functional polymorphisms and the placebo response in major depressive disorder.

Abstract
The placebo response shows pronounced interindividual variability. Placebos are postulated to act through central reward pathways that are modulated by monoamines. Because monoaminergic signaling is under strong genetic control, we hypothesized that common functional polymorphisms modulating monoaminergic tone would be related to degree of improvement during placebo treatment of subjects with major depressive disorder. We examined polymorphisms in genes encoding the catabolic enzymes catechol-O-methyltransferase and monoamine oxidase A. Subjects with monoamine oxidase A G/T polymorphisms (rs6323) coding for the highest activity form of the enzyme (G or G/G) had a significantly lower magnitude of placebo response than those with other genotypes. Subjects with ValMet catechol-O-methyltransferase polymorphisms coding for a lower-activity form of the enzyme (2 Met alleles) showed a statistical trend toward a lower magnitude of placebo response. These findings support the hypothesis that genetic polymorphisms modulating monoaminergic tone are related to degree of placebo responsiveness in major depressive disorder.
AuthorsAndrew F Leuchter, James T McCracken, Aimee M Hunter, Ian A Cook, Jonathan E Alpert
JournalJournal of clinical psychopharmacology (J Clin Psychopharmacol) Vol. 29 Issue 4 Pg. 372-7 (Aug 2009) ISSN: 1533-712X [Electronic] United States
PMID19593178 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antidepressive Agents
  • Monoamine Oxidase
  • Catechol O-Methyltransferase
Topics
  • Adult
  • Antidepressive Agents (therapeutic use)
  • Catechol O-Methyltransferase (genetics, metabolism)
  • Depressive Disorder, Major (drug therapy, enzymology, genetics)
  • Double-Blind Method
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Monoamine Oxidase (genetics, metabolism)
  • Phenotype
  • Placebo Effect
  • Polymorphism, Single Nucleotide
  • Randomized Controlled Trials as Topic
  • Severity of Illness Index
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: